Homing-associated molecules CD73 and VAP-1 as targets to prevent harmful inflammations and cancer spread

FEBS Letters

Volumn 585, Issue 11, 2011, Pages 1543-1550

  Salmi, Marko ^a,b   Jalkanen, Sirpa ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Cancer; Cell trafficking; Inflammation

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; ALPHA INTERFERON; AMINE OXIDASE (COPPER CONTAINING); AMINE OXIDASE (COPPER CONTAINING) INHIBITOR; BETA INTERFERON; BINDING PROTEIN; ENZYME INHIBITOR; HYDRAZINE DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MONOCLONAL ANTIBODY; SIGLEC 10 PROTEIN; SIGLEC 9 PROTEIN; UNCLASSIFIED DRUG; VASCULAR ADHESION PROTEIN 1; VASCULAR ADHESION PROTEIN 1 ANTIBODY; VASCULAR ADHESION PROTEIN 1 INHIBITOR;

ALLERGIC ENCEPHALOMYELITIS; ANTIANGIOGENIC ACTIVITY; CANCER CELL; CANCER GROWTH; CELL HOMING; CHRONIC INFLAMMATION; COLITIS; CONTACT DERMATITIS; DISEASE MARKER; DRUG EFFICACY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; EYE INFLAMMATION; HUMAN; LEUKOCYTE MIGRATION INHIBITION; LUNG INJURY; LYMPH NODE METASTASIS; LYMPH VESSEL ENDOTHELIUM; METASTASIS; METASTASIS INHIBITION; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEIC ACID SYNTHESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PSORIASIS; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; STROKE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; VASCULAR ENDOTHELIUM;

5'-NUCLEOTIDASE; ANIMALS; CELL ADHESION MOLECULES; CELL MOVEMENT; HUMANS; INFLAMMATION; NEOPLASMS;

EID: 79957553355     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2011.04.033     Document Type: Review

References (105)

1. K. Ley, C. Laudanna, M.I. Cybulsky, and S. Nourshargh Getting to the site of inflammation: the leukocyte adhesion cascade updated Nat. Rev. Immunol. 7 2007 678 689 (Pubitemid 47327397)
2. A.D. Luster, R. Alon, and U.H. von Andrian Immune cell migration in inflammation: present and future therapeutic targets Nat. Immunol. 6 2005 1182 1190 (Pubitemid 43045626)
3. D.X. Nguyen, P.D. Bos, and J. Massague Metastasis: from dissemination to organ-specific colonization Nat. Rev. Cancer 9 2009 274 284
4. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill Cancer-related inflammation Nature 454 2008 436 444
5. K. Ley, and G.S. Kansas Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation Nat. Rev. Immunol. 4 2004 325 335 (Pubitemid 38649275)
6. F. Sallusto, and M. Baggiolini Chemokines and leukocyte traffic Nat. Immunol. 9 2008 949 952
7. C.C. Denucci, J.S. Mitchell, and Y. Shimizu Integrin function in T-cell homing to lymphoid and nonlymphoid sites: getting there and staying there Crit. Rev. Immunol. 29 2009 87 109
8. S. Nourshargh, P.L. Hordijk, and M. Sixt Breaching multiple barriers: leukocyte motility through venular walls and the interstitium Nat. Rev. Mol. Cell Biol. 11 2010 366 378
9. C.V. Carman, and T.A. Springer Trans-cellular migration: cell-cell contacts get intimate Curr. Opin. Cell Biol. 20 2008 533 540
10. M. Salmi, and S. Jalkanen A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans Science 257 1992 1407 1409
11. M. Salmi, K. Kalimo, and S. Jalkanen Induction and function of vascular adhesion protein-1 at sites of inflammation J. Exp. Med. 178 1993 2255 2260 (Pubitemid 23344887)
12. G. Enrique-Tarancon Role of semicarbazide-sensitive amine oxidase on glucose transport and GLUT4 recruitment to the cell surface in adipose cells J. Biol. Chem. 273 1998 8025 8032 (Pubitemid 28168853)
13. M. Moldes, B. Feve, and J. Pairault Molecular cloning of a major mRNA species in murine 3T3 adipocyte lineage differentiation-dependent expression, regulation, and identification as semicarbazide-sensitive amine oxidase J. Biol. Chem. 274 1999 9515 9523
14. L. Marti, A. Abella, C. Carpene, M. Palacin, X. Testar, and A. Zorzano Combined treatment with benzylamine and low dosages of vanadate enhances glucose tolerance and reduces hyperglycemia in streptozotocin-induced diabetic rats Diabetes 50 2001 2061 2068 (Pubitemid 33643673)
15. C. Gokturk Overexpression of semicarbazide-sensitive amine oxidase in smooth muscle cells leads to an abnormal structure of the aortic elastic laminas Am. J. Pathol. 163 2003 1921 1928 (Pubitemid 37310022)
16. D.J. Smith, M. Salmi, P. Bono, J. Hellman, T. Leu, and S. Jalkanen Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule J. Exp. Med. 188 1998 17 27 (Pubitemid 28328602)
17. S. Jalkanen, and M. Salmi Cell surface monoamine oxidases: enzymes in search of a function EMBO J. 20 2001 3893 3901 (Pubitemid 32751805)
18. J.P. Klinman, and D. Mu Quinoenzymes in biology Annu. Rev. Biochem. 63 1994 299 344 (Pubitemid 24218636)
19. D. Mu, S.M. Janes, A.J. Smith, D.E. Brown, D.M. Dooley, and J.P. Klinman Tyrosine codon corresponds to topa quinone at the active site of copper amine oxidases J. Biol. Chem. 267 1992 7979 7982
20. T.T. Airenne Crystal structure of the human vascular adhesion protein-1: unique structural features with functional implications Protein Sci. 14 2005 1964 1974 (Pubitemid 41132362)
21. K. Ernberg A new crystal form of human vascular adhesion protein 1 Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 66 2010 1572 1578
22. G. McNab, J.L. Reeves, M. Salmi, S. Hubscher, S. Jalkanen, and D.H. Adams Vascular adhesion protein 1 mediates binding of T cells to human hepatic endothelium Gastroenterology 110 1996 522 528 (Pubitemid 26043886)
23. M. Salmi, P. Rajala, and S. Jalkanen Homing of mucosal leukocytes to joints. Distinct endothelial ligands in synovium mediate leukocyte-subtype specific adhesion J. Clin. Invest. 99 1997 2165 2172 (Pubitemid 27203772)
24. A.M. Arvilommi, M. Salmi, K. Kalimo, and S. Jalkanen Lymphocyte binding to vascular endothelium in inflamed skin revisited: a central role for vascular adhesion protein-1 (VAP-1) Eur. J. Immunol. 26 1996 825 833 (Pubitemid 26118294)
25. K. Jaakkola Vascular adhesion protein-1, intercellular adhesion molecule-1 and P-selectin mediate leukocyte binding to ischemic heart in humans J. Am. Coll. Cardiol. 36 2000 122 129 (Pubitemid 30466122)
26. R. Kurkijarvi, S. Jalkanen, H. Isoniemi, and M. Salmi Vascular adhesion protein-1 (VAP-1) mediates lymphocyte-endothelial interactions in chronic kidney rejection Eur. J. Immunol. 31 2001 2876 2884 (Pubitemid 32994538)
27. K. Koskinen, P.J. Vainio, D.J. Smith, M. Pihlavisto, S. Yla-Herttuala, S. Jalkanen, and M. Salmi Granulocyte transmigration through the endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-1) Blood 103 2004 3388 3395 (Pubitemid 38525669)
28. P.F. Lalor, S. Edwards, G. McNab, M. Salmi, S. Jalkanen, and D.H. Adams Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells J. Immunol. 169 2002 983 992 (Pubitemid 34753457)
29. A.I. Aspinall, S.M. Curbishley, P.F. Lalor, C.J. Weston, E. Liaskou, R.M. Adams, A.P. Holt, and D.H. Adams CX(3)CR1 and vascular adhesion protein-1-dependent recruitment of CD16(+) monocytes across human liver sinusoidal endothelium Hepatology 51 2010 2030 2039
30. S. Tohka, M. Laukkanen, S. Jalkanen, and M. Salmi Vascular adhesion protein 1 (VAP-1) functions as a molecular brake during granulocyte rolling and mediates recruitment in vivo FASEB J. 15 2001 373 382 (Pubitemid 32141429)
31. C.M. Stolen Absence of the endothelial oxidase AOC3 leads to abnormal leukocyte traffic in vivo Immunity 22 2005 105 115 (Pubitemid 40143455)
32. M. Merinen, H. Irjala, M. Salmi, I. Jaakkola, A. Hanninen, and S. Jalkanen Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse Am. J. Pathol. 166 2005 793 800 (Pubitemid 40315636)
33. C.S. Bonder Rules of recruitment for Th1 and Th2 lymphocytes in inflamed liver: a role for alpha-4 integrin and vascular adhesion protein-1 Immunity 23 2005 153 163 (Pubitemid 41169285)
34. T. Martelius, V. Salaspuro, M. Salmi, L. Krogerus, K. Hockerstedt, S. Jalkanen, and I. Lautenschlager Blockade of vascular adhesion protein-1 inhibits lymphocyte infiltration in rat liver allograft rejection Am. J. Pathol. 165 2004 1993 2001 (Pubitemid 39578377)
35. P. Dunkel Semicarbazide-sensitive amine oxidase/vascular adhesion protein 1: recent developments concerning substrates and inhibitors of a promising therapeutic target Curr. Med. Chem. 15 2008 1827 1839
36. H. Kinemuchi, H. Sugimoto, T. Obata, N. Satoh, and S. Ueda Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues Neurotoxicology 25 2004 325 335 (Pubitemid 38044193)
37. M. Salmi, G.G. Yegutkin, R. Lehvonen, K. Koskinen, T. Salminen, and S. Jalkanen A cell surface amine oxidase directly controls lymphocyte migration Immunity 14 2001 265 276 (Pubitemid 32289291)
38. F. Marttila-Ichihara Vascular amine oxidases are needed for leukocyte extravasation into inflamed joints in vivo Arthritis Rheum. 54 2006 2852 2862 (Pubitemid 44497764)
39. L.M. Salter-Cid, E. Wang, A.M. O'Rourke, A. Miller, H. Gao, L. Huang, A. Garcia, and M.D. Linnik Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase J. Pharmacol. Exp. Ther. 315 2005 553 562 (Pubitemid 41500719)
40. H.L. Xu, L. Salter-Cid, M.D. Linnik, E.Y. Wang, C. Paisansathan, and D.A. Pelligrino Vascular adhesion protein-1 plays an important role in postischemic inflammation and neuropathology in diabetic, estrogen-treated ovariectomized female rats subjected to transient forebrain ischemia J. Pharmacol. Exp. Ther. 317 2006 19 29
41. A.M. O'Rourke Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4- methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity J. Pharmacol. Exp. Ther. 324 2008 867 875 (Pubitemid 351185861)
42. A.M. O'Rourke Benefit of inhibiting SSAO in relapsing experimental autoimmune encephalomyelitis J. Neural Transm. 114 2007 845 849 (Pubitemid 46980496)
43. K. Noda Inhibition of vascular adhesion protein-1 suppresses endotoxin-induced uveitis FASEB J. 22 2008 1094 1103 (Pubitemid 351519964)
44. K. Noda, S. Nakao, S. Zandi, V. Engelstadter, Y. Mashima, and A. Hafezi-Moghadam Vascular adhesion protein-1 regulates leukocyte transmigration rate in the retina during diabetes Exp. Eye Res. 89 2009 774 781
45. K. Noda Vascular adhesion protein-1 blockade suppresses choroidal neovascularization FASEB J. 22 2008 2928 2935
46. A. Nakao, H. Nakajima, H. Tomioka, T. Nishimura, and I. Iwamoto Induction of T cell tolerance by pretreatment with anti-ICAM-1 and anti-lymphocyte function-associated antigen-1 antibodies prevents antigen-induced eosinophil recruitment into the mouse airways J. Immunol. 153 1994 5819 5825
47. Q. Zhang Characterization of AOC2 gene encoding a copper-binding amine oxidase expressed specifically in retina Gene 318 2003 45 53 (Pubitemid 37338390)
48. L. Almulki, K. Noda, S. Nakao, T. Hisatomi, K.L. Thomas, and A. Hafezi-Moghadam Localization of vascular adhesion protein-1 (VAP-1) in the human eye Exp. Eye Res. 90 2010 26 32
49. K. Koskinen, S. Nevalainen, M. Karikoski, A. Hanninen, S. Jalkanen, and M. Salmi VAP-1-deficient mice display defects in mucosal immunity and antimicrobial responses: implications for antiadhesive applications J. Immunol. 179 2007 6160 6168
50. J. Mercader, Z. Iffiu-Soltesz, S. Bour, and C. Carpene Oral administration of semicarbazide limits weight gain together with inhibition of fat deposition and of primary amine oxidase activity in adipose tissue J. Obes. 2011 2011475786. Epub 2011 Feb 8., 475786
51. S. Bour Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 deficiency reduces leukocyte infiltration into adipose tissue and favors fat deposition Am. J. Pathol. 174 2009 1075 1083
52. H. Irjala, M. Salmi, K. Alanen, R. Grenman, and S. Jalkanen Vascular adhesion protein 1 mediates binding of immunotherapeutic effector cells to tumor endothelium J. Immunol. 166 2001 6937 6943 (Pubitemid 32467241)
53. F. Marttila-Ichihara, K. Auvinen, K. Elima, S. Jalkanen, and M. Salmi Vascular adhesion protein-1 enhances tumor growth by supporting recruitment of Gr-1+CD11b+ myeloid cells into tumors Cancer Res. 69 2009 7875 7883
54. F. Marttila-Ichihara, K. Castermans, K. Auvinen, M.G. Oude Egbrink, S. Jalkanen, A.W. Griffioen, and M. Salmi Small-molecule inhibitors of vascular adhesion protein-1 reduce the accumulation of myeloid cells into tumors and attenuate tumor growth in mice J. Immunol. 184 2010 3164 3173
55. H.J. Forman, M. Maiorino, and F. Ursini Signaling functions of reactive oxygen species Biochemistry (Mosc.) 49 2010 835 842
56. G. Enrique-Tarancon Substrates of semicarbazide-sensitive amine oxidase co-operate with vanadate to stimulate tyrosine phosphorylation of insulin-receptor-substrate proteins, phosphoinositide 3-kinase activity and GLUT4 translocation in adipose cells Biochem. J. 350 Pt 1 2000 171 180
57. P.F. Lalor, P.J. Sun, C.J. Weston, A. Martin-Santos, M.J. Wakelam, and D.H. Adams Activation of vascular adhesion protein-1 on liver endothelium results in an NF-kappaB-dependent increase in lymphocyte adhesion Hepatology 45 2007 465 474 (Pubitemid 46374603)
58. M. Sole, M. Hernandez-Guillamon, M. Boada, and M. Unzeta P53 phosphorylation is involved in vascular cell death induced by the catalytic activity of membrane-bound SSAO/VAP-1 Biochim. Biophys. Acta 1783 2008 1085 1094
59. S. Jalkanen, M. Karikoski, N. Mercier, K. Koskinen, T. Henttinen, K. Elima, K. Salmivirta, and M. Salmi The oxidase activity of vascular adhesion protein-1 (VAP-1) induces endothelial E- and P-selectins and leukocyte binding Blood 110 2007 1864 1870 (Pubitemid 47443898)
60. E. Liaskou Regulation of mucosal addressin cell adhesion molecule 1 expression in human and mice by vascular adhesion protein 1 amine oxidase activity Hepatology 53 2011 661 672
61. E. Kivi Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate Blood 114 2009 5385 5392
62. P.R. Crocker, J.C. Paulson, and A. Varki Siglecs and their roles in the immune system Nat. Rev. Immunol. 7 2007 255 266 (Pubitemid 46480955)
63. K. Jaakkola In vivo detection of vascular adhesion protein-1 in experimental inflammation Am. J. Pathol. 157 2000 463 471 (Pubitemid 30626909)
64. R. Kurkijarvi, D.H. Adams, R. Leino, T. Mottonen, S. Jalkanen, and M. Salmi Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases J. Immunol. 161 1998 1549 1557 (Pubitemid 28380589)
65. A. Abella, S. Garcia-Vicente, N. Viguerie, A. Ros-Baro, M. Camps, M. Palacin, A. Zorzano, and L. Marti Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner Diabetologia 47 2004 429 438 (Pubitemid 38491239)
66. R. Kurkijarvi, G.G. Yegutkin, B.K. Gunson, S. Jalkanen, M. Salmi, and D.H. Adams Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease Gastroenterology 119 2000 1096 1103
67. F. Boomsma, A.H. van den Meiracker, S. Winkel, H.J. Aanstoot, M.R. Batstra, A.J. Man in 't Veld, and G.J. Bruining Circulating semicarbazide- sensitive amine oxidase is raised both in type I (insulin-dependent), in type II (non-insulin-dependent) diabetes mellitus and even in childhood type I diabetes at first clinical diagnosis Diabetologia 42 1999 233 237 (Pubitemid 29064246)
68. Z. Meszaros, T. Szombathy, L. Raimondi, I. Karadi, L. Romics, and K. Magyar Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride Metabolism 48 1999 113 117 (Pubitemid 29035570)
69. H. Garpenstrand, J. Ekblom, L.B. Backlund, L. Oreland, and U. Rosenqvist Elevated plasma semicarbazide-sensitive amine oxidase (SSAO) activity in Type 2 diabetes mellitus complicated by retinopathy Diabet. Med. 16 1999 514 521
70. O. Kemik, A. Sumer, A.S. Kemik, V. Itik, A.C. Dulger, S. Purisa, and S. Tuzun Human vascular adhesion protein-1 (VAP-1): serum levels for hepatocellular carcinoma in non-alcoholic and alcoholic fatty liver disease World J. Surg. Oncol. 8 2010 83
71. H. Yasuda, Y. Toiyama, M. Ohi, Y. Mohri, C. Miki, and M. Kusunoki Serum soluble vascular adhesion protein-1 is a valuable prognostic marker in gastric cancer J. Surg. Oncol. 103 2011 695 699
72. P. Bono, S. Jalkanen, and M. Salmi Mouse vascular adhesion protein 1 is a sialoglycoprotein with enzymatic activity and is induced in diabetic insulitis Am. J. Pathol. 155 1999 1613 1624
73. P.J. Vainio, O. Kortekangas-Savolainen, J.H. Mikkola, K. Jaakkola, K. Kalimo, S. Jalkanen, and T. Veromaa Safety of blocking vascular adhesion protein-1 in patients with contact dermatitis Basic Clin. Pharmacol. Toxicol. 96 2005 429 435 (Pubitemid 40835697)
74. S. Jalkanen, and M. Salmi VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation Arterioscler. Thromb. Vasc. Biol. 28 2008 18 26
75. G.G. Yegutkin Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade Biochim. Biophys. Acta 1783 2008 673 694
76. J. Stagg, and M.J. Smyth Extracellular adenosine triphosphate and adenosine in cancer Oncogene 29 2010 5346 5358
77. B. Zhang CD73: a novel target for cancer immunotherapy Cancer Res. 70 2010 6407 6411
78. T. Henttinen, S. Jalkanen, and G.G. Yegutkin Adherent leukocytes prevent adenosine formation and impair endothelial barrier function by Ecto-5′-nucleotidase/CD73-dependent mechanism J. Biol. Chem. 278 2003 24888 24895 (Pubitemid 37548648)
79. A. Algars, M. Karikoski, G.G. Yegutkin, P. Stoitzner, J. Niemela, M. Salmi, and S. Jalkanen Different role of CD73 in leukocyte trafficking via blood and lymph vessels Blood 117 2011 4387 4393
80. R. Pieters Expression of 5′-nucleotidase (CD73) related to other differentiation antigens in leukemias of B-cell lineage Blood 78 1991 488 492
81. J. Niemela, T. Henttinen, G.G. Yegutkin, L. Airas, A.M. Kujari, P. Rajala, and S. Jalkanen IFN-alpha induced adenosine production on the endothelium: a mechanism mediated by CD73 (ecto-5′-nucleotidase) up-regulation J. Immunol. 172 2004 1646 1653 (Pubitemid 38116812)
82. P. Ujhazy, M. Klobusicka, O. Babusikova, P. Strausbauch, E. Mihich, and M.J. Ehrke Ecto-5′-nucleotidase (CD73) in multidrug-resistant cell lines generated by doxorubicin Int. J. Cancer 59 1994 83 93 (Pubitemid 24310953)
83. W. Gutensohn, and E. Thiel Prognostic implication of ecto-5′- nucleotidase activity in acute lymphoblastic leukemia Cancer 66 1990 1755 1758 (Pubitemid 20381212)
84. R. Leth-Larsen, R. Lund, H.V. Hansen, A.V. Laenkholm, D. Tarin, O.N. Jensen, and H.J. Ditzel Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry Mol Cell Proteomics 8 2009 1436 1449
85. H. Lee, E.C. Lin, L. Liu, and J.W. Smith Gene expression profiling of tumor xenografts: In vivo analysis of organ-specific metastasis Int. J. Cancer 107 2003 528 534 (Pubitemid 37296111)
86. A. Mikhailov CD73 participates in cellular multiresistance program and protects against TRAIL-induced apoptosis J. Immunol. 181 2008 464 475
87. J. Stagg, U. Divisekera, N. McLaughlin, J. Sharkey, S. Pommey, D. Denoyer, K.M. Dwyer, and M.J. Smyth Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis Proc. Natl. Acad. Sci. USA 107 2010 1547 1552
88. D. Jin CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression Cancer Res. 70 2010 2245 2255
89. S. Deaglio Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression J. Exp. Med. 204 2007 1257 1265 (Pubitemid 46919862)
90. G.G. Yegutkin, F. Marttila-Ichihara, M. Karikoski, J. Niemela, J. Laurila, K. Elima, S. Jalkanen, and M. (Salmi Altered purinergic signalling in CD73 deficient mice inhibits tumor progression by regulating immunosuppressive leukocytes Eur. J. Immunol. 41 2011 1231 1241
91. J. Stagg, U. Divisekera, H. Duret, T. Sparwasser, M.W. Teng, P.K. Darcy, and M.J. Smyth CD73-deficient mice have increased anti-tumor immunity and are resistant to experimental metastasis Cancer Res. 71 2011 2892 2900
92. H.K. Eltzschig, L.F. Thompson, J. Karhausen, R.J. Cotta, J.C. Ibla, S.C. Robson, and S.P. Colgan Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism Blood 104 2004 3986 3992 (Pubitemid 39620148)
93. A. Zernecke CD73/ecto-5′-nucleotidase protects against vascular inflammation and neointima formation Circulation 113 2006 2120 2127
94. M.L. Hart, A. Grenz, I.C. Gorzolla, J. Schittenhelm, J.H. Dalton, and H.K. Eltzschig Hypoxia-Inducible Factor-1{alpha}-dependent protection from intestinal ischemia/reperfusion injury involves ecto-5′-nucleotidase (CD73) and the A2B adenosine receptor J. Immunol. 186 2011 4367 4374
95. P. Koszalka Targeted disruption of cd73/ecto-5′-nucleotidase alters thromboregulation and augments vascular inflammatory response Circ. Res. 95 2004 814 821 (Pubitemid 39390584)
96. J. Kiss, G.G. Yegutkin, K. Koskinen, T. Savunen, S. Jalkanen, and M. Salmi IFN-beta protects from vascular leakage via up-regulation of CD73 Eur. J. Immunol. 37 2007 3334 3338
97. J.H. Mills, L.F. Thompson, C. Mueller, A.T. Waickman, S. Jalkanen, J. Niemela, L. Airas, and M.S. Bynoe CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis Proc. Natl. Acad. Sci. USA 105 2008 9325 9330
98. J. Niemela, I. Ifergan, G.G. Yegutkin, S. Jalkanen, A. Prat, and L. Airas IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier Eur. J. Immunol. 38 2008 2718 2726
99. C. St Hilaire NT5E mutations and arterial calcifications N. Engl. J. Med. 364 2011 432 442
100. P. Meijer Rosuvastatin increases extracellular adenosine formation in humans in vivo: a new perspective on cardiovascular protection Arterioscler. Thromb. Vasc. Biol. 29 2009 963 968
101. R. Merla, I.N. Daher, Y. Ye, B.F. Uretsky, and Y. Birnbaum Pretreatment with statins may reduce cardiovascular morbidity and mortality after elective surgery and percutaneous coronary intervention: clinical evidence and possible underlying mechanisms Am. Heart J. 154 2007 391 402 (Pubitemid 47071895)
102. S. Ledoux, D. Laouari, M. Essig, I. Runembert, G. Trugnan, J.B. Michel, and G. Friedlander Lovastatin enhances ecto-5′-nucleotidase activity and cell surface expression in endothelial cells: implication of rho-family GTPases Circ. Res. 90 2002 420 427 (Pubitemid 34633911)
103. P. Fishman, S. Bar-Yehuda, G. Ohana, F. Barer, A. Ochaion, A. Erlanger, and L. Madi An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3 beta and NF-kappa B Oncogene 23 2004 2465 2471 (Pubitemid 38520744)
104. S. Jajoo, D. Mukherjea, K. Watabe, and V. Ramkumar Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity Neoplasia 11 2009 1132 1145
105. S. Bar-Yehuda The A3 adenosine receptor agonist CF102 induces apoptosis of hepatocellular carcinoma via de-regulation of the Wnt and NF-kappaB signal transduction pathways Int. J. Oncol. 33 2008 287 295